Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-21-003345
Filing Date
2021-02-26
Accepted
2021-02-25 18:42:41
Documents
96
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K aeri-20201231.htm   iXBRL 10-K 2883695
2 EX-4.3 aeriex-43descriptionofther.htm EX-4.3 24321
3 EX-10.32 aeriex-1032aeriepharmaceut.htm EX-10.32 612898
4 EX-23.1 aeri12312020ex-231.htm EX-23.1 2134
5 EX-31.1 aeri12312020ex-311.htm EX-31.1 12428
6 EX-31.2 aeri12312020ex-312.htm EX-31.2 11843
7 EX-32.1 aeri12312020ex-321.htm EX-32.1 7004
8 EX-32.2 aeri12312020ex-322.htm EX-32.2 6334
14 aeri-20201231_g1.jpg GRAPHIC 13447
15 aeri-20201231_g2.jpg GRAPHIC 13674
16 aeri-20201231_g3.jpg GRAPHIC 60342
17 aeri-20201231_g4.jpg GRAPHIC 27201
18 aeri-20201231_g5.jpg GRAPHIC 69467
  Complete submission text file 0001628280-21-003345.txt   11892112

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aeri-20201231.xsd EX-101.SCH 61673
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aeri-20201231_cal.xml EX-101.CAL 106024
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aeri-20201231_def.xml EX-101.DEF 334233
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aeri-20201231_lab.xml EX-101.LAB 808972
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aeri-20201231_pre.xml EX-101.PRE 530968
19 EXTRACTED XBRL INSTANCE DOCUMENT aeri-20201231_htm.xml XML 1763026
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

EIN.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36152 | Film No.: 21682529
SIC: 2836 Biological Products, (No Diagnostic Substances)